Fischer Medical Ventures

40.79
-2.15
(-5.01%)
hide
Key Fundamentals
Add Ratio
Market Cap
2,645.29 Cr
EPS
0.08
PE Ratio
139.03
Dividend Yield
0.01 %
Industry
Chemicals
52 Week High
124.70
52 Week Low
42.94
PB Ratio
7.77
Debt to Equity
0.21
Forecast For
Actual

Company News

View All News
Caret
positive
Fischer Medical Ventures reported consolidated net profit of 139 million rupees in Q2, compared to 3 million rupees in the same period last year. The company's revenue increased to 863 million rupees from 397 million rupees year-over-year.
positive
Fischer Medical Ventures' Nanomedic Secures UK NHS Approval and CDSCO License for SpinCare DeviceOct 23, 2025
Fischer Medical Ventures announced that its subsidiary Nanomedic has successfully overcome a UK NHS challenge and obtained a license from CDSCO for its SpinCare device. The company has introduced plans for the India market and is targeting a US FDA filing for the medical device.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
810.85
#1 20,656.91
52.16
#1 15,112.00
-3.79
354
-42.32
28.05
1,415.50
17,868.96
18.46
10,355.20
17.69
#1 945
-0.05
49.95
491.80
7,226.54
11.37
8,393.40
-0.07
586
70.48
42.95
99.75
6,010.51
9,500.00
35.30
#1 11,666.67
1
-25.00
62.19
599.95
5,763.84
10.24
3,271.20
-6.51
624
-31.07
45.38
311.95
4,932.23
#1 -23.07
4,393.10
9.61
-110
-62.94
21.38
547.75
4,022.96
27,745.00
4,165.00
6.89
-65
189.56
46.09
3,931.05
3,921.25
42.31
559.90
45.35
88
-10.88
47.70
82.27
3,730.25
24.62
1,180.00
7.28
157
2.66
42.17
40.79
#10 2,645.29
#8 139.03
#9 112.20
#2 421.86
#7 1
#1 4,533.33
16.68
Growth Rate
Revenue Growth
421.86 %
Net Income Growth
-33.33 %
Cash Flow Change
-1,080.14 %
ROE
-84.14 %
ROCE
-71.21 %
EBITDA Margin (Avg.)
-60.78 %

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Apr 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
28 Apr 2023 8.84 9.88
13 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
13 Jan 2024 18.65 25.30
29 Mar 2024 CHANGE OF NAME Change Of Name
NA
29 Mar 2024 62.47 62.47
17 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
17 Sept 2024 70.45 68.74
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 63.39 64.90
31 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jan 2025 69.82 70.10
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 70.83 71.72
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 82.99 85.02
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 97.34 95.53
28 Jul 2025 SPLIT Split
1:10
12 Sept 2025 94.49 94.49
22 Sept 2025 DIVIDEND Dividend
0.00 /share
22 Sept 2025 85.02 113.60
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 95.53 113.55
28 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2025 99.35 111.08

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.09%
7
0.00%
0.09%

Technical Indicators

RSI(14)
Oversold
16.68
ATR(14)
Less Volatile
6.89
STOCH(9,6)
Oversold
0.51
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-5.51
ADX(14)
Strong Trend
41.26
UO(9)
Bullish
11.86
ROC(12)
Downtrend And Accelerating
-59.90
WillR(14)
Oversold
-100.00